Sign in
GBLX Stock Price, Chart, Stats & News
GB Sciences, Inc.
Save
GB Sciences, Inc. (GBLX) does not currently pay a dividend.
40,707
Market cap
–
Current P/E
–
Forward P/E
GBLX chart
About
Health care
Sector
Biotechnology
Industry
Operating across North America and Europe, GB Sciences, Inc. is dedicated to the research and development of plant-based pharmaceuticals. The company specializes in crafting cannabinoid-inspired medications and complex therapeutic formulations intended for the prescription drug market. Its extensive intellectual property portfolio addresses a variety of medical conditions, with programs currently in pre-clinical animal stages.
Similar securities
Based on sector and market capitalization
Report issue